Publications by authors named "Eric Schaeffer"

Claim this Profile
D
Developing a Gene Therapy for the Treatment of Autosomal Dominant Alzheimer's Disease.
Benjamin Moore, Apurwa Sharma, Martin Goulet, Tracey Suter, Carolyn Pelletier, Eric Schaeffer

Hum Gene Ther· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of kynurenic acid in rat cerebrospinal fluid by HPLC with fluorescence detection.
Ye Bao, David Luchetti, Eric Schaeffer, Jingfang Cutrone

Biomed Chromatogr· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioanalysis of acetylcarnitine in cerebrospinal fluid by HILIC-mass spectrometry.
Brian R Holder, Colleen A McNaney, David Luchetti, Eric Schaeffer, Dieter M Drexler

Biomed Chromatogr· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of acute NR2B antagonist treatment on long-term potentiation in the rat hippocampus.
John D Graef, Kimberly Newberry, Amy Newton, Rick Pieschl, Eric Shields, Eric Schaeffer

Brain Res· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addressing the need for biomarker liquid chromatography/mass spectrometry assays: a protocol for effective method development for the bioanalysis of endogenous compounds in cerebrospinal fluid.
Yulia Benitex, Colleen A McNaney, David Luchetti, Eric Schaeffer, Timothy V Olah

Rapid Commun Mass Spectrom· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The discovery of a structurally novel class of inhibitors of the type 1 glycine transporter.
John A Lowe, Xinjun Hou, Christopher Schmidt, F David Tingley, Stan McHardy, Eric Schaeffer

Bioorg Med Chem Lett· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An inhibitor of casein kinase I epsilon induces phase delays in circadian rhythms under free-running and entrained conditions.
Lori Badura, Terri Swanson, Wendy Adamowicz, Jessica Adams, Julie Cianfrogna, Eric Schaeffer

J Pharmacol Exp Ther· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation.
Jotham W Coe, Paige R Brooks, Michael G Vetelino, Michael C Wirtz, Eric P Arnold, Eric Schaeffer

J Med Chem· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis